Biotech Expo & Conference 2016

SPEAKER INFORMATION:

Keynote Speakers

Karimah Es Sabar

President & CEO, CDRD

A highly-recognized Canadian life sciences leader with broad global experience, Karimah Es Sabar has had a successful career spanning start-up companies, multi-national pharmaceutical/biotechnology companies, and not-for-profit organizations. Ms. Es Sabar joined The Centre for Drug Research and Development, Canada’s national drug development and commercialization centre, in 2009 as Senior Vice-President, Business and Strategic Affairs, leading its business functions, and successfully building an array of national and international alliances and strategic industry partnerships. In 2011, she then took on the role of President and CEO responsible for developing and executing on the overall strategic direction of the organization. Since Ms. Es Sabar joined CDRD, she has enabled new public and private sector support in excess of $90M, grown the organization with expanded national and international reach to include partnerships right across Canada, and in eight countries on five continents – firmly establishing its reputation as one of the world’s leading pre-clinical translational research centres. In this vein, Ms. Es Sabar was also appointed Founding Chair of the Global Alliance of Leading Drug Discovery and Development Centres in 2013, an association of international peer organizations dedicated to translating health research into new medicines, the formation of which she spearheaded.

Ms. Es Sabar holds a BSc Joint Honours degree in Biochemistry/Chemistry from the University of Salford, England, a MSc. degree in Neurochemistry from the Institute of Psychiatry, University of London, England, and an Executive Certificate in Management and Leadership from the MIT Sloan School of Management.

Session Speakers

Carl Hansen

CEO & President, AbCellera

Dr. Hansen is CEO and co-founder of AbCellera, and is also an Associate Professor in the Michael Smith Labs and Center for High-Throughput Biology at UBC. Prior to joining UBC in 2005, Dr. Hansen did his undergraduate training in Engineering Physics and Mathematics at UBC (2000), completed a PhD in Applied Physics and Biotechnology at Caltech (2004), and trained as a postdoctoral fellow with Leroy Hood at the Institute for Systems Biology in Seattle (2005). He is a co-inventor of AbCellera’s single cell platform that was developed in his research group at UBC, is an author on more than 40 publications, has given over 100 scientific talks, and is an inventor on 46 international and US patent applications related to microfluidics, immunology and single cell analysis research (34 issued and 11 pending). His work has contributed to a suite of commercial products by Fluidigm corporation, including PCR-based genomics platforms (Dynamic Array™, the Access Array™, and the Digital Array™), and the widely adopted C1™ single cell analysis system. Dr. Hansen has founded three startup companies from his lab including AbCellera (www.abcellera.com), Precision Nanosystems (www.precisionnanosystems.com), and Resolution Diagnostics, a new company advancing disruptive single cell genomics technology. Carl lives in Vancouver with his wife and three children. Outside of work his interests include athletics, reading and leadership.

Dr. Martin Dawes, MBBS, MD., FRCGP

Royal Canadian Legion Professor and Head Department of Family Practice, UBC

Professor Dawes is Head of family practice at the University of British Columbia. He started his clinical practice as a family physician in Oxford and looked after 1800 patients for 17 years. He provided full office practice, obstetrics, home care, and in-hospital care. In 1992 following the completion of his PhD he helped develop a Masters programme in Evidence Based Health Care at the University of Oxford. He ran the UK Centre for Evidence-Based Medicine in Oxford and was Professor & Head of family practice at McGill University before coming to UBC in 2010. His research includes ambulatory blood pressure monitoring, implementation of pharmacogenomics in primary care, and lifestyle interventions to prevent diabetes, while for pleasure he enjoys fishing and messing about on boats.

Michael Bidu

CEO, Interface Health

Michael Bidu is the Founder and CEO of Interface Health Society, which is a Canadian not-for-profit digital health technology accelerator based in Vancouver, BC. Michael is a serial entrepreneur, an award-winning marketer, speaker, mentor and advisor with seven Internet, wireless and not-for-profit start-ups under his belt and 25 years of experience in technology, innovation, business and creativity. Since 2009 his special area of interest is the convergence between health, technology, design, social media, digital arts and business.

Nina Bagri

National Sales Manager, STEMCELL Technologies

TBA

Exhibitors

Amgen

BC Bioenergy

CDRD

Genentech

GenomeDx Biosciences

Kelly Services

Precision Nanosystems

SignalChem

STEMCELL Technologies

UBC Pharmaceutical Sciences